Skip to content

Author

J. Thaventhiran

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Human-relevant disease models to accelerate the development of nucleic acid-based therapies and other advanced therapeutics.

Advanced therapeutics, including programmable nucleic acid-based therapies (NATs), such as small interfering RNAs (siRNAs), antisense oligonucleotides (ASOs), CRISPR-Cas 9 editing systems, modified in vitro transcribed messenger RNAs (mRNAs) and Adeno-associated viruses (AAVs), have the potential to transform healthcar...

M. Colin, J. Thaventhiran, A. Willis · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.